COMIRNATY XFG Pfizer Australia Pty Ltd
Product name
COMIRNATY XFG
Sponsor
Accepted date
Jul-2026
Active ingredients
SARS-CoV-2 spike protein (mRNA) XFG
Summary of proposed indication
COMIRNATY XFG is an mRNA-based vaccine proposed for immunising people aged 6 months and older against COVID-19. It is designed to target the XFG variant, a newer version of the SARS-CoV-2 virus.
Application type
A (new medicine)
Publication date
Jul-2026